Long non-coding RNA LINC01133 inhibits epithelial–mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6

Cancer Letters

Volumn 380, Issue 2, 2016, Pages 476-484

  Kong, Jianlu ^a   Sun, Wenjie ^a   Li, Chen ^a   Wan, Ledong ^a   Wang, Shuo ^a   Wu, Yihua ^a   Xu, Enping ^a   Zhang, Honghe ^a   Lai, Maode ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; EMT; lncRNA; Metastasis; SRSF6

Indexed keywords

LINC01133; LONG UNTRANSLATED RNA; SERINE ARGININE RICH SPLICING FACTOR; SRSF6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; CADHERIN; CDH1 PROTEIN, HUMAN; LONG NON-CODING RNA LINC01133, HUMAN; PHOSPHOPROTEIN; SRSF6 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN RNA BINDING; RECURRENCE FREE SURVIVAL; ANIMAL; CELL MOTION; COLORECTAL TUMOR; GENETIC TRANSFECTION; GENETICS; HCT 116 CELL LINE; HT-29 CELL LINE; LUNG TUMOR; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; RNA INTERFERENCE; SCID MOUSE; SECONDARY; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR VOLUME;

ANIMALS; CADHERINS; CELL MOVEMENT; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; HCT116 CELLS; HT29 CELLS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE, INBRED NOD; MICE, SCID; PHOSPHOPROTEINS; RNA INTERFERENCE; RNA, LONG NONCODING; SERINE-ARGININE SPLICING FACTORS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; VIMENTIN;

EID: 84979256700     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.07.015     Document Type: Article

References (30)

1. [1] Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W., Comber, H., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer 49 (2013), 1374–1403.
2. [2] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J. Clin 65 (2015), 5–29.
3. [3] Nieto, M.A., Huang, R.Y., Jackson, R.A., Thiery, J.P., EMT: 2016. Cell 166 (2016), 21–45.
4. [4] Tsai, J.H., Yang, J., Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27 (2013), 2192–2206.
5. [5] De Craene, B., Berx, G., Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13 (2013), 97–110.
6. [6] Thiery, J.P., Sleeman, J.P., Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol 7 (2006), 131–142.
7. [7] Zhang, J., Tian, X.J., Zhang, H., Teng, Y., Li, R., Bai, F., et al. TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci. Signal, 7, 2014, ra91.
8. [8] Lee, J.T., Epigenetic regulation by long noncoding RNAs. Science 338 (2012), 1435–1439.
9. [9] Ulitsky, I., Bartel, D.P., lincRNAs: genomics, evolution, and mechanisms. Cell 154 (2013), 26–46.
10. [10] Necsulea, A., Soumillon, M., Warnefors, M., Liechti, A., Daish, T., Zeller, U., et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 505 (2014), 635–640.
11. [11] Geisler, S., Coller, J., RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat. Rev. Mol. Cell Biol 14 (2013), 699–712.
12. [12] Brockdorff, N., Noncoding RNA and polycomb recruitment. RNA 19 (2013), 429–442.
13. [13] Tripathi, V., Ellis, J.D., Shen, Z., Song, D.Y., Pan, Q., Watt, A.T., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39 (2010), 925–938.
14. [14] Cooper, D.R., Carter, G., Li, P., Patel, R., Watson, J.E., Patel, N.A., Long non-coding RNA NEAT1 associates with SRp40 to temporally regulate PPARgamma2 splicing during adipogenesis in 3T3-L1 cells. Genes (Basel) 5 (2014), 1050–1063.
15. [15] Zhang, J., Zhu, N., Chen, X., A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival. Tumor Biol 36 (2015), 7465–7471.
16. [16] Wu, W., Bhagat, T.D., Yang, X., Song, J.H., Cheng, Y., Agarwal, R., et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology, 144, 2013 956–966 e954.
17. [17] Chu, C., Quinn, J., Chang, H.Y., Chromatin isolation by RNA purification (ChIRP). J. Vis. Exp, 61, 2012, 3912, 10.3791/3912.
18. [18] Marisa, L., de Reynies, A., Duval, A., Selves, J., Gaub, M.P., Vescovo, L., et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med, 10, 2013, e1001453.
19. [19] Zang, C., Nie, F.Q., Wang, Q., Sun, M., Li, W., He, J., et al. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer. Oncotarget 7 (2016), 11696–11707.
20. [20] Ponting, C.P., Oliver, P.L., Reik, W., Evolution and functions of long noncoding RNAs. Cell 136 (2009), 629–641.
21. [21] Yang, X., Song, J.H., Cheng, Y., Wu, W., Bhagat, T., Yu, Y., et al. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 63 (2014), 881–890.
22. [22] Fan, Y., Shen, B., Tan, M., Mu, X., Qin, Y., Zhang, F., et al. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin. Cancer Res 20 (2014), 1531–1541.
23. [23] Gupta, R.A., Shah, N., Wang, K.C., Kim, J., Horlings, H.M., Wong, D.J., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464 (2010), 1071–1076.
24. [24] Zhang, H., Cai, K., Wang, J., Wang, X., Cheng, K., Shi, F., et al. MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway. Stem Cells 32 (2014), 2858–2868.
25. [25] Änkö, M.-L., Regulation of gene expression programmes by serine–arginine rich splicing factors. Semin. Cell Dev. Biol 32 (2014), 11–21.
26. [26] Gout, S., Brambilla, E., Boudria, A., Drissi, R., Lantuejoul, S., Gazzeri, S., et al. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma. PLoS ONE, 7, 2012 e46539.
27. [27] Edmond, V., Merdzhanova, G., Gout, S., Brambilla, E., Gazzeri, S., Eymin, B., A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors. Cell Cycle 12 (2013), 1267–1278.
28. [28] Das, S., Krainer, A.R., Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol. Cancer Res 12 (2014), 1195–1204.
29. [29] Cohen-Eliav, M., Golan-Gerstl, R., Siegfried, Z., Andersen, C.L., Thorsen, K., Orntoft, T.F., et al. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. J. Pathol 229 (2013), 630–639.
30. [30] Jensen, M.A., Wilkinson, J.E., Krainer, A.R., Splicing factor SRSF6 promotes hyperplasia of sensitized skin. Nat. Struct. Mol. Biol 21 (2014), 189–197.